Surgery Partners, Inc. Segments Disclosure
| Year Ended December 31, | ||||||||||||||||||||
| 2025 | 2024 | 2023 | ||||||||||||||||||
| Surgical Facilities Revenues | $ | 3,308.7 | $ | 3,114.3 | $ | 2,743.3 | ||||||||||||||
Less: | ||||||||||||||||||||
Salaries and benefits | 971.0 | 907.5 | 793.8 | |||||||||||||||||
Supplies | 878.9 | 812.9 | 745.0 | |||||||||||||||||
Professional and medical fees | 404.5 | 357.1 | 296.8 | |||||||||||||||||
| Lease expense | 87.9 | 89.5 | 84.9 | |||||||||||||||||
Other segment items (1) | 340.2 | 337.3 | 288.5 | |||||||||||||||||
| 2,682.5 | 2,504.3 | 2,209.0 | ||||||||||||||||||
| Adjusted Surgical Facilities EBITDA | $ | 626.2 | $ | 610.0 | $ | 534.3 | ||||||||||||||
Reconciliation: | ||||||||||||||||||||
| Add back: Net income attributable to non-controlling interests | (176.8) | (180.6) | (147.2) | |||||||||||||||||
| Unallocated amounts: | ||||||||||||||||||||
| General and administrative expenses | 118.2 | 138.7 | 120.9 | |||||||||||||||||
| Transaction and integration costs | 73.9 | 100.1 | 61.7 | |||||||||||||||||
| Other corporate expenses | 45.4 | 50.4 | 52.8 | |||||||||||||||||
| Depreciation and amortization | 176.0 | 152.6 | 118.1 | |||||||||||||||||
| Interest expense, net | 272.6 | 201.7 | 193.0 | |||||||||||||||||
| Income before income taxes | $ | 116.9 | $ | 147.1 | $ | 135.0 | ||||||||||||||
| Year Ended December 31, | ||||||||||||||||||||
| 2025 | 2024 | 2023 | ||||||||||||||||||
| Depreciation and amortization: | ||||||||||||||||||||
| Surgical Facilities | $ | 164.8 | $ | 138.9 | $ | 110.8 | ||||||||||||||
| All other | 11.2 | 13.7 | 7.3 | |||||||||||||||||
| Total depreciation and amortization expense | $ | 176.0 | $ | 152.6 | $ | 118.1 | ||||||||||||||
| December 31, 2025 | December 31, 2024 | |||||||||||||
| Assets: | ||||||||||||||
Surgical Facilities | $ | 7,643.9 | $ | 7,466.3 | ||||||||||
| All other | 475.8 | 423.7 | ||||||||||||
| Total assets | $ | 8,119.7 | $ | 7,890.0 | ||||||||||
| Year Ended December 31, | ||||||||||||||||||||
| 2025 | 2024 | 2023 | ||||||||||||||||||
| Cash purchases of property and equipment: | ||||||||||||||||||||
Surgical Facilities | $ | 77.9 | $ | 86.6 | $ | 88.7 | ||||||||||||||
| All other | 0.8 | 3.8 | 0.1 | |||||||||||||||||
| Total cash purchases of property and equipment | $ | 78.7 | $ | 90.4 | $ | 88.8 | ||||||||||||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Mar 2, 2026 | Showing above |
| 2024 | Mar 7, 2025 | |
| 2023 | Feb 26, 2024 | |
| 2022 | Mar 1, 2023 | |
| 2021 | Mar 1, 2022 | |
| 2020 | Mar 10, 2021 | |
| 2019 | Mar 13, 2020 | |
| 2018 | Mar 15, 2019 | |
| 2017 | Mar 16, 2018 | |
| 2016 | Mar 10, 2017 | |
| 2015 | Mar 11, 2016 | |
About Segments Disclosures
Segment disclosures break a company into its reportable operating units, revealing revenue, profit, and asset allocation that consolidated financial statements obscure. Under ASC 280, segments must match how the chief operating decision maker views the business, providing a window into internal management structure and resource allocation priorities.
Key signals: compare segment margins to identify which units drive profitability and which destroy value. Watch for changes in the number of reportable segments — segment aggregation or disaggregation often coincides with strategic shifts or attempts to obscure declining performance. Intersegment elimination patterns reveal internal pricing practices. The reconciliation between segment totals and consolidated figures exposes corporate overhead allocation and unallocated items. Geographic revenue concentration highlights regulatory and currency exposure. Compare segment-level capital expenditure against segment revenue to assess where management is investing for future growth versus harvesting existing assets.